Clinical trials
Ischemic Stroke trials in Austria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2003 | 1 |
| 2005 | 3 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 4 |
| 2010 | 3 |
| 2013 | 1 |
| 2014 | 3 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Recruiting | 10 |
| Terminated | 6 |
| Active, not recruiting | 3 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Insel Gruppe AG, University Hospital Bern | 5 |
| Ever Neuro Pharma GmbH | 3 |
| VASCage GmbH | 3 |
| Abbott Medical Devices | 2 |
| Astellas Pharma Inc | 2 |
| Bayer | 2 |
| Sigmund Freud PrivatUniversitat | 2 |
| AtriCure, Inc. | 1 |
| Biotronik SE & Co. KG | 1 |
| Bristol-Myers Squibb | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ischemic Stroke | 46 |
| Stroke | 16 |
| Hemorrhagic Stroke | 6 |
| Ischemic Attack, Transient | 6 |
| Atrial Fibrillation | 5 |
| Coronary Artery Disease | 3 |
| Anemia | 2 |
| Hematologic Diseases | 2 |
| Hemostatic Disorders | 2 |
| Ischemia | 2 |
Trials
Showing 76 to 46 of 46. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.